The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Zhou Jiming | Chief Operating Officer | Grant(A) | 150K | — | $0 |
| Apr 2, 2026 | Bergman Alan B. | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Mar 3, 2026 | Cohen Jonathan M | Chief Executive Officer, Director, 10% Owner | Grant(A) | 353K | — | $0 |
| Feb 19, 2026 | Cohen Richard M | Director | Conversion(C) | 8K | — | $0 |
| Feb 19, 2026 | Cohen Richard M | Director | Conversion(C) | 8K | — | — |
| Feb 19, 2026 | Compton John G. | Director | Conversion(C) | 8K | — | $0 |
| Feb 19, 2026 | Compton John G. | Director | Conversion(C) | 8K | — | — |
| Feb 19, 2026 | Ross Michael A. | Director | Conversion(C) | 31 | — | $0 |
| Feb 19, 2026 | Ross Michael A. | Director | Conversion(C) | 31 | — | — |
| Feb 19, 2026 | Rollins John Woodson | Director | Conversion(C) | 13K | — | $0 |
| Feb 19, 2026 | Rollins John Woodson | Director | Conversion(C) | 6K | — | $0 |
| Feb 19, 2026 | Rollins John Woodson | Director | Conversion(C) | 13K | — | — |
| Feb 19, 2026 | Rollins John Woodson | Director | Conversion(C) | 6K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: 20/20 Biolabs, Inc., SEC CIK 0001139685. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AIDX and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AIDX